BioPharma
German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Phar...
March 01, 2022 | News
Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing...
February 28, 2022 | News
During the three-year collaboration, multiple undisclosed targets (including undruggable targets) were screened against HitGen's proprietary DNA encoded ch...
February 25, 2022 | News
Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...
February 18, 2022 | News
Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...
February 11, 2022 | News
The state-of-the-art site marks a significant expansion of the company's advanced protein and gene platforms, and is designed to provide high quality...
February 10, 2022 | News
This follows a successful PoC (Proof of Concept) study where the hydrogel formulation developed by Nanoform (CESS®2 technology-based nanoparticles...
February 07, 2022 | News
Germfree’s biomanufacturing platform addresses current industry needs, while de-risking and future-proofing for a rapidly evolving industry. "The ind...
February 03, 2022 | News
Dr. Michael Quirmbach, Chief Executive Officer & President of CordenPharma said, "We welcome the three sites and their employees as new members to...
February 02, 2022 | News
In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...
February 01, 2022 | News
BRUKINSA was granted its first breakthrough therapy designation in China with this application The application is supported by SEQUOIA trial results, whic...
January 31, 2022 | News
This strategic partnership will accelerate I-Mab's commercialization strategy with an execution plan and timeline to commercialize its innovative assets, i...
January 31, 2022 | News
Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facil...
January 28, 2022 | News
Solid tumor has long been a challenge for CAR-T. Major obstacles include solid tumor heterogeneity, lack of tumor associated antigens as CAR-T targets, com...
January 25, 2022 | News
Most Read
Bio Jobs
News
Editor Picks